While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

When you catch a cold or the flu, a sore throat is often a symptom, making swallowing and talking uncomfortable. With ...

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

ENFLONSIA demonstrated a reduction in incidence of RSV-associated medically attended lower respiratory infections (MALRI) requiring ≥1 indicator of lower respiratory infection (LRI) or severity ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.